S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NYSE:WST

West Pharmaceutical Services (WST) Stock Forecast, Price & News

$375.21
-3.87 (-1.02%)
(As of 09/29/2023 ET)
Compare
Today's Range
$374.86
▼
$380.38
50-Day Range
$355.15
▼
$412.48
52-Week Range
$206.19
▼
$415.73
Volume
221,568 shs
Average Volume
447,431 shs
Market Capitalization
$27.71 billion
P/E Ratio
54.70
Dividend Yield
0.20%
Price Target
$361.00
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

West Pharmaceutical Services MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
3.8% Downside
$361.00 Price Target
Short Interest
Healthy
1.21% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
1.33mentions of West Pharmaceutical Services in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$22.71 M Sold Last Quarter
Proj. Earnings Growth
11.97%
From $7.85 to $8.79 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

167th out of 972 stocks

Surgical & Medical Instruments Industry

26th out of 101 stocks

See Top Rated MarketRank™ Stocks Here

WST stock logo

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

WST Price History

WST Stock News Headlines

September 28, 2023 | benzinga.com
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $9,100 Today
September 25, 2023 | finance.yahoo.com
These Are The 12 Stocks Driving The S&P 500 Higher In 2023
September 29, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
September 8, 2023 | benzinga.com
How Is The Market Feeling About West Pharmaceutical Servs?
September 8, 2023 | finance.yahoo.com
Unpacking the Investment Potential of West Pharmaceutical Services Inc (WST): A Deep Dive into ...
September 7, 2023 | marketwatch.com
West Pharmaceutical Services Inc. stock falls Thursday, still outperforms market
August 31, 2023 | benzinga.com
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years
August 30, 2023 | finance.yahoo.com
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
September 29, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
August 23, 2023 | benzinga.com
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
August 21, 2023 | markets.businessinsider.com
What 4 Analyst Ratings Have To Say About West Pharmaceutical Servs
August 18, 2023 | finance.yahoo.com
The Zacks Analyst Blog Highlights Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services
August 16, 2023 | benzinga.com
$100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth This Much Today
August 15, 2023 | finance.yahoo.com
Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
August 9, 2023 | msn.com
West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
August 8, 2023 | finance.yahoo.com
Is West Pharmaceutical Services Inc (WST) Fairly Valued?
July 28, 2023 | msn.com
Keybanc Maintains West Pharmaceutical Services (WST) Overweight Recommendation
July 27, 2023 | seekingalpha.com
West Pharmaceutical Services, Inc. 2023 Q2 - Results - Earnings Call Presentation
July 27, 2023 | msn.com
West Pharmaceutical (WST) Q2 Earnings Beat, HVP Drives Sales
July 27, 2023 | finance.yahoo.com
West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
July 26, 2023 | benzinga.com
A Look Into West Pharmaceutical Servs Inc's Price Over Earnings
July 25, 2023 | benzinga.com
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
July 18, 2023 | msn.com
Stephens & Co. Maintains West Pharmaceutical Services (WST) Overweight Recommendation
July 17, 2023 | finance.yahoo.com
5 Stocks to Buy From the Prospering Dental Supplies Industry
July 13, 2023 | finance.yahoo.com
West to Host Second-Quarter 2023 Conference Call
June 29, 2023 | finance.yahoo.com
Veeva (VEEV) Falls Nearly 3% on Morgan Stanley Downgrade
June 22, 2023 | finance.yahoo.com
Should You Hold West Pharmaceutical Services (WST) for the Long-Term?
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Company Calendar

Ex-Dividend for 8/2 Dividend
7/25/2023
Last Earnings
7/27/2023
Dividend Payable
8/02/2023
Today
9/29/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NYSE:WST
CUSIP
95530610
CIK
105770
Web
www.westpharma.com
Phone
(610) 594-2900
Fax
800-345-9800
Employees
13,550
Year Founded
1923

Price Target and Rating

Average Stock Price Forecast
$361.00
High Stock Price Forecast
$440.00
Low Stock Price Forecast
$250.00
Forecasted Upside/Downside
-4.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$6.86
Trailing P/E Ratio
55.09
Forward P/E Ratio
48.14
P/E Growth
8.09
Net Income
$585.90 million
Net Margins
18.10%
Pretax Margin
21.20%
Return on Equity
22.36%
Return on Assets
16.67%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
3.66
Quick Ratio
2.78

Sales & Book Value

Annual Sales
$2.89 billion
Price / Sales
9.67
Cash Flow
$10.47 per share
Price / Cash Flow
36.09
Book Value
$36.22 per share
Price / Book
10.43

Miscellaneous

Outstanding Shares
73,860,000
Free Float
73,026,000
Market Cap
$27.91 billion
Optionable
Optionable
Beta
1.08

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Eric M. GreenMr. Eric M. Green (Age 53)
    Chair, Pres & CEO
    Comp: $1.92M
  • Mr. Bernard J. BirkettMr. Bernard J. Birkett (Age 54)
    Sr. VP and Chief Financial & Operations Officer
    Comp: $985.12k
  • Mr. Silji AbrahamMr. Silji Abraham (Age 51)
    Sr. VP & Chief Technology Officer
    Comp: $711.9k
  • Ms. Kimberly Banks MacKay (Age 57)
    Sr. VP, Gen. Counsel & Company Sec.
    Comp: $850.04k
  • Ms. Cindy Reiss-ClarkMs. Cindy Reiss-Clark (Age 49)
    Sr. VP & Chief Commercial Officer
    Comp: $775.49k
  • Mr. Chad R. Winters (Age 44)
    VP, Chief Accounting Officer & Corp. Controller
  • Dr. Quintin J. Lai C.F.A. (Age 56)
    Ph.D., VP of Strategy & Investor Relations
  • Michele Polinsky
    VP of Global Communications
  • Ms. Annette F. FavoriteMs. Annette F. Favorite (Age 58)
    Chief HR Officer & Sr. VP
  • Mr. Christopher G. Ryan (Age 62)
    Sr. VP of Containment & Glass Systems

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













WST Stock - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" WST shares.
View WST analyst ratings or view top-rated stocks.

What is West Pharmaceutical Services' stock price forecast for 2023?

5 analysts have issued twelve-month target prices for West Pharmaceutical Services' shares. Their WST share price forecasts range from $250.00 to $440.00. On average, they anticipate the company's share price to reach $361.00 in the next year. This suggests that the stock has a possible downside of 4.5%.
View analysts price targets for WST or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2023?

West Pharmaceutical Services' stock was trading at $235.35 on January 1st, 2023. Since then, WST stock has increased by 60.6% and is now trading at $377.89.
View the best growth stocks for 2023 here.

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our WST earnings forecast.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, July, 27th. The medical instruments supplier reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.95 by $0.16. The medical instruments supplier had revenue of $753.80 million for the quarter, compared to the consensus estimate of $755.71 million. West Pharmaceutical Services had a trailing twelve-month return on equity of 22.36% and a net margin of 18.10%. The firm's revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.47 EPS.
Read the conference call transcript.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, April 27th. Investors of record on Wednesday, July 26th will be paid a dividend of $0.19 per share on Wednesday, August 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date is Tuesday, July 25th.
Read our dividend analysis for WST.

What ETFs hold West Pharmaceutical Services' stock?

ETFs with the largest weight of West Pharmaceutical Services (NYSE:WST) stock in their portfolio include Subversive Mental Health ETF (SANE), BTD Capital Fund (DIP), Formidable Fortress ETF (KONG), Nuveen ESG Mid-Cap Growth ETF (NUMG), Goldman Sachs Future Health Care Equity ETF (GDOC), BlackRock Future Health ETF (BMED), Fidelity Disruptive Medicine ETF (FMED) and First Trust Indxx Medical Devices ETF (MDEV).

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.20%. The company has been increasing its dividend for 30 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 11.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 8.65% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $7.65-$7.80 for the period, compared to the consensus EPS estimate of $7.71. The company issued revenue guidance of $2.97 billion-$3.00 billion, compared to the consensus revenue estimate of $2.98 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $377.89.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services (NYSE:WST) has a market capitalization of $27.91 billion and generates $2.89 billion in revenue each year. The medical instruments supplier earns $585.90 million in net income (profit) each year or $6.86 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

The company employs 13,550 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for the company is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.

This page (NYSE:WST) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -